EX-10.15 4 dex1015.htm SUBLICENSE AGREEMENT WITH GENPHARM INTERNATIONAL, INC. [CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS AGREEMENT HAVE BEEN REDACTED AND SEPARATELY FILED WITH THE COMMISSION.] UNITED STATES PATENT APPLICATION NO....Sublicense Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionThis Agreement is made this 1st day of January, 1991, by and between GenPharm International, Inc., a company duly organized and existing under the laws of the State of California, with its principal offices at 2375 Garcia Avenue, Mountain View, CA 94043 (hereinafter referred to as “Sublicensor”), and DNX, Inc., a company duly formed and existing under the laws of the State of Ohio, with its principal offices at 303B College Road East, Princeton Forrestal Center, Princeton, New Jersey 08540 (hereinafter referred to as “Sublicensee”);
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS AGREEMENT HAVE BEEN REDACTED AND SEPARATELY FILED WITH THE COMMISSION.]Sublicense Agreement • May 3rd, 2004 • Xenogen Corp • Services-commercial physical & biological research • California
Contract Type FiledMay 3rd, 2004 Company Industry JurisdictionThis Agreement is made this 1st day of January, 1991, by and between GenPharm International, Inc., a company duly organized and existing under the laws of the State of California, with its principal offices at 2375 Garcia Avenue, Mountain View, CA 94043 (hereinafter referred to as “Sublicensor”), and DNX, Inc., a company duly formed and existing under the laws of the State of Ohio, with its principal offices at 303B College Road East, Princeton Forrestal Center, Princeton, New Jersey 08540 (hereinafter referred to as “Sublicensee”);